3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1/2
5
Phase 3
3
Phase 4
2
Phase 2/3
2
Phase 1
1
Status
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Tuberous Sclerosis
2
Autistic Disorder
2
Uterine Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Intellectual Disability
1
Hamartoma Syndrome, Multiple
1
Gastroenteropancreatic Neuroendocrine Tumors
1
Gallbladder Neoplasms
1
Adenoma, Islet Cell
1
Interventions
Sirolimus
2
Everolimus
2
Vigabatrin
1
Fluid Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Tuberous Sclerosis
×
Everolimus
×
Clear all
NCT02860494
2021-05-03
EVEROST
Hospices Civils de Lyon
Phase 2/3
Withdrawn
NCT01730209
2015-05-05
RAPIT
Erasmus Medical Center
Phase 2/3
Unknown
60 enrolled